Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NIMA (never in mitosis gene a)-related kinase 1 (NEK1) is a serine/threonine protein kinase that plays a key role in various cellular processes including cell cycle progression, DNA damage response, chromatin condensation, and regulation of the cytoskeleton, particularly microtubule dynamics[1][2][3]. NEK1 is essential for the proper function of the centrosome, assembly of the mitotic spindle, and the activation of the ATR-dependent DNA repair pathway[2]. It is implicated in multiple human diseases; loss-of-function mutations are associated with neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), as well as genetic ciliopathies and certain cancers[2][3]. NEK1 has a critical role in the phosphorylation of proteins involved in microtubule stability and nuclear import, highlighting its pleiotropic cellular functions[3]. Structural studies show NEK1 contains an N-terminal kinase domain and a large C-terminal domain with coiled-coil motifs, which mediate diverse protein-protein interactions[2]. While NEK1 is considered a promising therapeutic target, especially in oncology and neurodegeneration, drugs specifically targeting NEK1 kinase activity remain under early investigation[2][3][4].
Inhibition of kinase activity; Chemosensitization through disruption of DNA repair in cancer cells[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NIMA (never in mitosis gene a)-related kinase 1 (NEK1).